[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 281 Introduced in Senate (IS)]

<DOC>






117th CONGRESS
  1st Session
S. RES. 281

  Recognizing the 25th anniversary of the Foundation for the National 
  Institutes of Health and its critical role in America's biomedical 
 research strategy by advancing biomedical research and the mission of 
   the National Institutes of Health, the world's premier biomedical 
                            research agency.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             June 22, 2021

    Mrs. Murray (for herself and Mr. Burr) submitted the following 
 resolution; which was referred to the Committee on Health, Education, 
                          Labor, and Pensions

_______________________________________________________________________

                               RESOLUTION


 
  Recognizing the 25th anniversary of the Foundation for the National 
  Institutes of Health and its critical role in America's biomedical 
 research strategy by advancing biomedical research and the mission of 
   the National Institutes of Health, the world's premier biomedical 
                            research agency.

Whereas Congress chartered the Foundation for the National Institutes of Health 
        (referred to in this preamble as the ``FNIH'') to support the mission of 
        the National Institutes of Health (referred to in this preamble as the 
        ``NIH''), which is to advance research in pursuit of fundamental 
        knowledge that will lead to better health outcomes for all;
Whereas June 26, 2021, marks 25 years since FNIH commenced its work to improve 
        health outcomes for the people of the United States by facilitating 
        groundbreaking research and catalyzing innovation and discovery to 
        answer the toughest scientific questions;
Whereas FNIH is recognized by Congress, NIH, and the biomedical community as a 
        model for aligning public and private partners around a common cause 
        that advances breakthrough biomedical discoveries and improves the 
        quality of people's lives;
Whereas, among the hundreds of programs FNIH has facilitated, the Grand 
        Challenges in Global Health partnership, founded in collaboration with 
        the Bill & Melinda Gates Foundation, achieved scientific breakthroughs 
        against deadly diseases in the world's poorest countries and elevated 
        the role of FNIH as a leader in building alliances for biomedical 
        research;
Whereas FNIH, NIH, and the Food and Drug Administration of the Department of 
        Health and Human Services launched the Accelerating Medicines 
        Partnership as a public-private collaboration to pursue new methods to 
        develop diagnostics and treatments for Alzheimer's disease, type 2 
        diabetes, autoimmune disorders, Parkinson's disease, and schizophrenia;
Whereas the FNIH created a new model for clinical trials through initiatives to 
        fight breast cancer and lung cancer, continues to bring together 
        partners to identify, develop, and qualify biomarkers to improve drug 
        discovery and regulatory decision making, and recognizes and supports 
        trailblazing researchers, some of whom have won other prestigious 
        scientific prizes, including the Nobel Prize;
Whereas FNIH supports caregivers of NIH Clinical Center patients through the 
        Edmond J. Safra Family Lodge, a temporary residence for caregivers whose 
        close presence helps to sustain patients who volunteer for NIH research 
        that was constructed and is maintained by the FNIH on the NIH campus;
Whereas FNIH answered NIH's call to action to address the largest pandemic in a 
        century by launching and coordinating the Accelerating COVID-19 
        Therapeutic Interventions and Vaccines (``ACTIV'') initiative in 
        partnership with numerous government agencies, not-for-profit 
        organizations, and biopharmaceutical companies to accelerate the most 
        promising COVID-19 vaccines and treatments; and
Whereas FNIH remains an indispensable institution to the biomedical research 
        mission of the NIH and the people of the United States: Now, therefore, 
        be it
    Resolved, That the Senate--
            (1) celebrates the 25th anniversary of the Foundation for 
        the National Institutes of Health and its critical role in 
        advancing biomedical research and the mission of the National 
        Institutes of Health, the world's premier biomedical research 
        agency;
            (2) applauds the Foundation for the National Institutes of 
        Health for its leadership and ongoing efforts to advance human 
        health outcomes through innovative public-private partnerships 
        that achieve groundbreaking biomedical research results;
            (3) commends the Foundation for the National Institutes of 
        Health for its efforts to address the COVID-19 pandemic through 
        the Accelerating COVID-19 Therapeutic Interventions and 
        Vaccines initiative and accelerate the development of the most 
        promising treatments and vaccines for COVID-19; and
            (4) reiterates that the Foundation for the National 
        Institutes of Health, in partnership with the National 
        Institutes of Health, is a vital and essential component of 
        biomedical research strategy of the United States.
                                 <all>